dr. herbst on nivolumab for nsclc
Published 9 years ago • 296 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
1:14
dr. herbst on long term survival with pembrolizumab in nsclc
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
1:01
dr. heymach on nivolumab for lung cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:00
dr. herbst discusses immunotherapy in lung cancer
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
3:16
dr herbst on the evolution of targeted therapies for egfr nsclc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials